[HTML][HTML] Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria

VC Thai, KA Stubbs, M Sarkar-Tyson, CM Kahler - Antibiotics, 2023 - mdpi.com
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria

V Thai, K Stubbs, M Sarkar-Tyson… - …, 2023 - research-repository.uwa.edu.au
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria

V Thai, K Stubbs, M Sarkar-Tyson… - Antibiotics (Basel …, 2023 - europepmc.org
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria

VC Thai, KA Stubbs… - Antibiotics (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria.

VC Thai, KA Stubbs, M Sarkar-Tyson… - Antibiotics (2079 …, 2023 - search.ebscohost.com
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria

VC Thai, KA Stubbs, M Sarkar-Tyson, CM Kahler - Antibiotics, 2023 - search.proquest.com
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine transferases as drug discovery targets for therapeutic treatment of multi-drug resistant pathogenic gram-negative bacteria.

VC Thai, KA Stubbs, M Sarkar-Tyson, CM Kahler - 2023 - cabidigitallibrary.org
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria.

VC Thai, KA Stubbs, M Sarkar-Tyson, CM Kahler - Antibiotics, 2023 - go.gale.com
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

[HTML][HTML] Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria

VC Thai, KA Stubbs, M Sarkar-Tyson, CM Kahler - Antibiotics, 2023 - ncbi.nlm.nih.gov
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …

Phosphoethanolamine Transferases as Drug Discovery Targets for Therapeutic Treatment of Multi-Drug Resistant Pathogenic Gram-Negative Bacteria.

VC Thai, KA Stubbs, M Sarkar-Tyson… - Antibiotics (Basel …, 2023 - europepmc.org
Antibiotic resistance caused by multidrug-resistant (MDR) bacteria is a major challenge to
global public health. Polymyxins are increasingly being used as last-in-line antibiotics to …